I agree. It's only up just over 15% for the year and yet PNV is in a much better position now than then.
The MOU is great but will be even better when it is converted into a contract with favourable terms.
The sawtooth is always a feature of sp rises over time as it will be in this case but there's too much good stuff to come for there to be an actual correction.
If I had taken shares in the placement and inclined to take a quick profit I would hold off taking it now and wait for more revenue news to come through (the breast contract terms, BTM sales updates etc.).
Ann: PolyNovo signs MOU for global breast partnership, page-12
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.45 |
Change
0.010(0.41%) |
Mkt cap ! $1.691B | |||
| Open | High | Low | Value | Volume |
| $2.45 | $2.51 | $2.43 | $5.243M | 2.122M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35541 | $2.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.46 | 2681 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PNV (ASX) Chart |